跳至主要内容
临床试验/NL-OMON46897
NL-OMON46897已完成不适用

Cognitive Behavioural Therapy for anxiety disorders in patients with Parkinson*s disease: a Randomized, Controlled Trial of the clinical effectiveness and changes in cerebral connectivity - Cognitive behavioural therapy for anxiety disorders in PD

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 30 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • * Idiopathic PD according to the Queens Square Brain Bank diagnostic criteria
  • * Presence of clinically relevant anxiety symptoms
  • * Using a stable dose of levodopa or other antiparkinsonian medication for at least one month
  • * No other current psychological treatment for anxiety; pharmacotherapy (e.g., SSRIs) is allowed if a stable dose is used at least 2 months prior to participation and the patient still meets inclusion criteria. During the trial the dosage should not be changed. Medication use and mental health care will be tracked throughout the study.
  • * Age between 35 and 80 years
  • * Signed informed consent

排除标准

  • * Parkinsonian syndromes or neurodegenerative disorders other than PD
  • * Dementia or severe cognitive decline
  • * Major depressive disorder (MDD) as defined by the criteria of a DSM-V diagnosis for MDD
  • * Abuse of alcohol, drugs or benzodiazepines.

研究者

发起方
Medisch Universitair Ziekenhuis Maastricht

相似试验